P2X7受体在乳腺癌进展中的作用
Yanan Du1, Yahui Cao1, Wei Song1
1School of Medical Laboratory, Shandong Second Medical University, Shandong, 261053, China.
Purinergic signalling
|July 22, 2024
概括
乳腺癌的进展与P2X7受体 (P2X7R) 有关. 用抑制剂或天然抗剂向P2X7R显示出新的乳腺癌治疗方法的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 乳腺癌是女性癌症死亡的主要原因,其发病率越来越高.
- 精氨酸连接体带离子通道7受体 (P2X7R) 与瘤发生和癌症进展有关.
- P2X7R与腺三酸盐 (ATP) 相互作用,并且在乳腺癌中被上调.
研究的目的:
- 审查P2X7R在乳腺癌发育和进展中的作用.
- 探索P2X7R作为乳腺癌的潜在治疗点.
- 要总结P2X7R向乳腺癌治疗的最新进展.
主要方法:
- 对研究乳腺癌P2X7R的研究进行文献综述.
- 对P2X7R参与关键癌症途径 (AKT,EMT,EVs,COX-2) 的分析.
- 检查P2X7R在乳腺癌细胞增殖和亡中的作用.
主要成果:
- P2X7R通过AKT信号传递,EMT,EV生成和COX-2调节促进乳腺癌的侵袭和转移.
- P2X7R显著影响乳腺癌细胞增殖和亡.
- P2X7R的抑制剂和天然抗剂在临床前模型中显示出有效性.
结论:
- P2X7R是乳腺癌进展的关键调解者.
- 准P2X7R为乳腺癌提供了一个有前途的治疗策略.
- 像柏柏林这样的天然化合物显示出对乳腺癌治疗的P2X7R抗剂的潜力.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


